Human Gene MIR518D (ENST00000385014.3) from GENCODE V44
|
|
Sequence and Links to Tools and Databases
|
|
Primer design for this transcript
|
|
Comparative Toxicogenomics Database (CTD)
|
|
The following chemicals interact with this gene
| |
|
|
Microarray Expression Data
|
|
Press "+" in the title bar above to open this section.
| |
|
|
Orthologous Genes in Other Species
|
|
Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
Mouse | Rat | Zebrafish | D. melanogaster | C. elegans | S. cerevisiae |
No ortholog | No ortholog | No ortholog | No ortholog | No ortholog | No ortholog |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
|
| |
|
|
Descriptions from all associated GenBank mRNAs
|
|
DM004879 - METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. DM175476 - A nucleics Acid regulating cell growth. FV527622 - Nucleic acid controling mast cell degranulation. FW422221 - METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HI979158 - Sequence 85 from Patent EP2234483. HV342540 - JP 2011510623-A/85: METHODS AND COMPOSITIONS FOR DIAGNOSING COMPLICATIONS OF PREGNANCY. HV534387 - WO 2011111715-A/903: Nucleic acid for controlling cell cycle. HW105356 - JP 2013502906-A/53: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF TUMOR INVOLVING CHROMOSOMAL REARRANGEMENTS. HW368092 - JP 2012228254-A/759: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HW674831 - JP 2014217381-A/759: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HZ067773 - JP 2014012020-A/759: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HZ408522 - JP 2015528002-A/1119: CHIRAL CONTROL. HZ428197 - JP 2014217384-A/759: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HZ429000 - JP 2014217385-A/759: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HZ429803 - JP 2014217386-A/759: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HZ430606 - JP 2014217387-A/759: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HZ769863 - JP 2014223080-A/759: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. JA059257 - Sequence 759 from Patent EP2298893. JA060060 - Sequence 759 from Patent EP2298894. JA074383 - Sequence 759 from Patent EP2281887. JA105520 - Sequence 759 from Patent EP2302051. JA106860 - Sequence 759 from Patent EP2302052. JA107663 - Sequence 759 from Patent EP2302053. JA108466 - Sequence 759 from Patent EP2302054. JA109269 - Sequence 759 from Patent EP2302055. JA110072 - Sequence 759 from Patent EP2302056. JA134474 - Sequence 46 from Patent WO2011036398. JA171097 - Sequence 53 from Patent WO2011023413. JA172742 - Sequence 53 from Patent WO2011023414. JA218700 - Sequence 759 from Patent EP2281888. JA226851 - Sequence 759 from Patent EP2292755. JA229706 - Sequence 759 from Patent EP2292756. JA257977 - Sequence 759 from Patent EP2284265. JA279257 - Sequence 759 from Patent EP2281886. JA285143 - Sequence 759 from Patent EP2281889. JA293196 - Sequence 759 from Patent EP2287303. JA318382 - Sequence 759 from Patent EP2314688. JA375441 - Sequence 759 from Patent EP2322616. JC991193 - Sequence 759 from Patent EP2808390. LF715296 - JP 2016165292-A/759: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. LG051856 - KR 1020150036642-A/1122: CHIRAL CONTROL. AY882327 - Homo sapiens microRNA HSA-MIR-RG-94, complete sequence. AY882336 - Homo sapiens microRNA HSA-MIR-RG-103, complete sequence. CS548507 - Sequence 1537 from Patent EP1777301. CS548538 - Sequence 1568 from Patent EP1777301. DM174535 - A nucleics Acid regulating cell growth. DM175339 - A nucleics Acid regulating cell growth. FW312269 - DETECTING NUCLEIC ACIDS. FW312293 - DETECTING NUCLEIC ACIDS. FW364393 - Oligonucleotides for modulating target RNA activity. FZ421151 - JP 2010539978-A/51: INCREASING ERYTHROPOIETIN USING NUCLEIC ACIDS HYBRIDIZABLE TO MICRO-RNA AND PRECURSORS THEREOF. FZ421175 - JP 2010539978-A/75: INCREASING ERYTHROPOIETIN USING NUCLEIC ACIDS HYBRIDIZABLE TO MICRO-RNA AND PRECURSORS THEREOF. HI964998 - Sequence 283 from Patent WO2010139812. HI966451 - Sequence 771 from Patent WO2010139811. HI967317 - Sequence 771 from Patent WO2010139810. HV533509 - WO 2011111715-A/25: Nucleic acid for controlling cell cycle. HV595301 - JP 2010539959-A/682: Micromirs. HW105364 - JP 2013502906-A/61: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF TUMOR INVOLVING CHROMOSOMAL REARRANGEMENTS. HW502465 - JP 2014050389-A/51: INCREASING ERYTHROPOIETIN USING NUCLEIC ACIDS HYBRIDIZABLE TO MICRO-RNA AND PRECURSORS THEREOF. HW502489 - JP 2014050389-A/75: INCREASING ERYTHROPOIETIN USING NUCLEIC ACIDS HYBRIDIZABLE TO MICRO-RNA AND PRECURSORS THEREOF. HW818097 - JP 2015500013-A/24: Expression of miRNAs in placental tissue. HZ074333 - JP 2013535982-A/424: Single-Stranded RNAi Agents Containing an Internal, Non-Nucleic Acid Spacer. HZ157858 - JP 2015130862-A/682: Micromirs. HZ186706 - JP 2015146814-A/455: Oligonucleotides for modulating target RNA activity. HZ482139 - JP 2015535430-A/2645: TERMINALLY MODIFIED RNA. HZ792070 - JP 2016504050-A/3815: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES. JA171105 - Sequence 61 from Patent WO2011023413. JA172750 - Sequence 61 from Patent WO2011023414. JA401036 - Sequence 283 from Patent WO2011080318. JA402014 - Sequence 283 from Patent WO2011080315. JA403021 - Sequence 283 from Patent WO2011080316. JA405652 - Sequence 283 from Patent EP2336353. JA427320 - Sequence 653 from Patent WO2011072177. JA429178 - Sequence 283 from Patent WO2011095623. JA791627 - Sequence 29 from Patent WO2012089772. JA792033 - Sequence 82 from Patent WO2012089753. JB620511 - Sequence 491 from Patent WO2013063544. JB730402 - Sequence 24 from Patent WO2013079701. JC037689 - Sequence 217 from Patent EP2643479. JC334393 - Sequence 311 from Patent EP2487240. JC514802 - Sequence 5055 from Patent WO2014113089. LF160823 - JP 2016513950-A/889: Oligomers with improved off-target profile. LP727077 - Sequence 771 from Patent EP2883966. LP819347 - Sequence 771 from Patent EP3296406. LP834140 - Sequence 24 from Patent EP3190186. LP939289 - Sequence 771 from Patent EP3184651. LQ072390 - Sequence 2714 from Patent EP2964234. LQ278675 - Sequence 214 from Patent WO2016066288. LY405366 - KR 1020160117535-A/671: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES. LZ234063 - JP 2017184756-A/455: Oligonucleotides for modulating target RNA activity. MA260605 - JP 2017505623-A/671: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES. MA267352 - JP 2018061445-A/86: Method for detecting urothelial cancer based on microRNA in urine using cell sorting. MA645891 - JP 2017113010-A/3815: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES. MA733775 - JP 2017140048-A/2645: TERMINALLY MODIFIED RNA. MP015076 - Sequence 279 from Patent WO2019016252. MS834137 - Sequence 283 from Patent EP3112479. DI443543 - KR 1020140074997-A/164: MICRORNAS IN NEURODEGENERATIVE DISORDERS. DI443544 - KR 1020140074997-A/165: MICRORNAS IN NEURODEGENERATIVE DISORDERS. DM175337 - A nucleics Acid regulating cell growth. DM175343 - A nucleics Acid regulating cell growth. FW364389 - Oligonucleotides for modulating target RNA activity. FW364407 - Oligonucleotides for modulating target RNA activity. FW364423 - Oligonucleotides for modulating target RNA activity. HI964968 - Sequence 253 from Patent WO2010139812. HI964984 - Sequence 269 from Patent WO2010139812. HI965002 - Sequence 287 from Patent WO2010139812. HI966103 - Sequence 423 from Patent WO2010139811. HI966150 - Sequence 470 from Patent WO2010139811. HI966280 - Sequence 600 from Patent WO2010139811. HI966969 - Sequence 423 from Patent WO2010139810. HI967016 - Sequence 470 from Patent WO2010139810. HI967146 - Sequence 600 from Patent WO2010139810. HI979148 - Sequence 75 from Patent EP2234483. HV342530 - JP 2011510623-A/75: METHODS AND COMPOSITIONS FOR DIAGNOSING COMPLICATIONS OF PREGNANCY. HV533872 - WO 2011111715-A/388: Nucleic acid for controlling cell cycle. HV533877 - WO 2011111715-A/393: Nucleic acid for controlling cell cycle. HV533880 - WO 2011111715-A/396: Nucleic acid for controlling cell cycle. HV595298 - JP 2010539959-A/679: Micromirs. HV943732 - JP 2012516688-A/208: METHODS OF DETECTING SEPSIS. HW105357 - JP 2013502906-A/54: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF TUMOR INVOLVING CHROMOSOMAL REARRANGEMENTS. HW105387 - JP 2013502906-A/84: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF TUMOR INVOLVING CHROMOSOMAL REARRANGEMENTS. HW105417 - JP 2013502906-A/114: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF TUMOR INVOLVING CHROMOSOMAL REARRANGEMENTS. HW105419 - JP 2013502906-A/116: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF TUMOR INVOLVING CHROMOSOMAL REARRANGEMENTS. HW608565 - JP 2014515024-A/54: Micro-RNA Inhibitors and Their Uses in Disease. HW807869 - JP 2014534810-A/164: MICRORNAS IN NEURODEGENERATIVE DISORDERS. HW807870 - JP 2014534810-A/165: MICRORNAS IN NEURODEGENERATIVE DISORDERS. HW818093 - JP 2015500013-A/20: Expression of miRNAs in placental tissue. HW818111 - JP 2015500013-A/38: Expression of miRNAs in placental tissue. HW818127 - JP 2015500013-A/54: Expression of miRNAs in placental tissue. HZ074337 - JP 2013535982-A/428: Single-Stranded RNAi Agents Containing an Internal, Non-Nucleic Acid Spacer. HZ157855 - JP 2015130862-A/679: Micromirs. HZ186702 - JP 2015146814-A/451: Oligonucleotides for modulating target RNA activity. HZ186720 - JP 2015146814-A/469: Oligonucleotides for modulating target RNA activity. HZ186736 - JP 2015146814-A/485: Oligonucleotides for modulating target RNA activity. HZ482135 - JP 2015535430-A/2641: TERMINALLY MODIFIED RNA. HZ482164 - JP 2015535430-A/2670: TERMINALLY MODIFIED RNA. HZ482180 - JP 2015535430-A/2686: TERMINALLY MODIFIED RNA. HZ792066 - JP 2016504050-A/3811: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES. HZ792095 - JP 2016504050-A/3840: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES. HZ792111 - JP 2016504050-A/3856: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES. JA171098 - Sequence 54 from Patent WO2011023413. JA171128 - Sequence 84 from Patent WO2011023413. JA171158 - Sequence 114 from Patent WO2011023413. JA171160 - Sequence 116 from Patent WO2011023413. JA172743 - Sequence 54 from Patent WO2011023414. JA172773 - Sequence 84 from Patent WO2011023414. JA172803 - Sequence 114 from Patent WO2011023414. JA172805 - Sequence 116 from Patent WO2011023414. JA401006 - Sequence 253 from Patent WO2011080318. JA401022 - Sequence 269 from Patent WO2011080318. JA401040 - Sequence 287 from Patent WO2011080318. JA401984 - Sequence 253 from Patent WO2011080315. JA402000 - Sequence 269 from Patent WO2011080315. JA402018 - Sequence 287 from Patent WO2011080315. JA402991 - Sequence 253 from Patent WO2011080316. JA403007 - Sequence 269 from Patent WO2011080316. JA403025 - Sequence 287 from Patent WO2011080316. JA405622 - Sequence 253 from Patent EP2336353. JA405638 - Sequence 269 from Patent EP2336353. JA405656 - Sequence 287 from Patent EP2336353. JA427116 - Sequence 449 from Patent WO2011072177. JA429148 - Sequence 253 from Patent WO2011095623. JA429164 - Sequence 269 from Patent WO2011095623. JA429182 - Sequence 287 from Patent WO2011095623. JA660699 - Sequence 153 from Patent WO2011131354. JA679065 - Sequence 208 from Patent EP2391738. JA791608 - Sequence 10 from Patent WO2012089772. JA791662 - Sequence 64 from Patent WO2012089772. JA791984 - Sequence 33 from Patent WO2012089753. JA792182 - Sequence 231 from Patent WO2012089753. JB022453 - Sequence 295 from Patent WO2013026685. JB022496 - Sequence 338 from Patent WO2013026685. JB023025 - Sequence 279 from Patent WO2013026684. JB023093 - Sequence 347 from Patent WO2013026684. JB049984 - Sequence 71 from Patent WO2013020926. JB050196 - Sequence 283 from Patent WO2013020926. JB158066 - Sequence 54 from Patent WO2012142313. JB620515 - Sequence 495 from Patent WO2013063544. JB620516 - Sequence 496 from Patent WO2013063544. JB620536 - Sequence 516 from Patent WO2013063544. JB730398 - Sequence 20 from Patent WO2013079701. JB730416 - Sequence 38 from Patent WO2013079701. JB730432 - Sequence 54 from Patent WO2013079701. JB733829 - Sequence 3232 from Patent WO2013082448. JC514798 - Sequence 5051 from Patent WO2014113089. JC514827 - Sequence 5080 from Patent WO2014113089. JC514843 - Sequence 5096 from Patent WO2014113089. JE867420 - Sequence 227 from Patent WO2015128671. JE978708 - Sequence 153 from Patent EP2865765. LF159947 - JP 2016513950-A/13: Oligomers with improved off-target profile. LF160712 - JP 2016513950-A/778: Oligomers with improved off-target profile. LF161627 - JP 2016513950-A/1693: Oligomers with improved off-target profile. LP726729 - Sequence 423 from Patent EP2883966. LP726776 - Sequence 470 from Patent EP2883966. LP726906 - Sequence 600 from Patent EP2883966. LP818999 - Sequence 423 from Patent EP3296406. LP819046 - Sequence 470 from Patent EP3296406. LP819176 - Sequence 600 from Patent EP3296406. LP834136 - Sequence 20 from Patent EP3190186. LP834154 - Sequence 38 from Patent EP3190186. LP834170 - Sequence 54 from Patent EP3190186. LP938941 - Sequence 423 from Patent EP3184651. LP938988 - Sequence 470 from Patent EP3184651. LP939118 - Sequence 600 from Patent EP3184651. LQ072386 - Sequence 2710 from Patent EP2964234. LQ072415 - Sequence 2739 from Patent EP2964234. LQ072431 - Sequence 2755 from Patent EP2964234. LQ278580 - Sequence 119 from Patent WO2016066288. LX154579 - JP 2017509333-A/227: Biomarkers for Endometriosis. LY405363 - KR 1020160117535-A/668: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES. LZ234059 - JP 2017184756-A/451: Oligonucleotides for modulating target RNA activity. LZ234077 - JP 2017184756-A/469: Oligonucleotides for modulating target RNA activity. LZ234093 - JP 2017184756-A/485: Oligonucleotides for modulating target RNA activity. MA260602 - JP 2017505623-A/668: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES. MA267347 - JP 2018061445-A/81: Method for detecting urothelial cancer based on microRNA in urine using cell sorting. MA267348 - JP 2018061445-A/82: Method for detecting urothelial cancer based on microRNA in urine using cell sorting. MA267349 - JP 2018061445-A/83: Method for detecting urothelial cancer based on microRNA in urine using cell sorting. MA645887 - JP 2017113010-A/3811: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES. MA645916 - JP 2017113010-A/3840: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES. MA645932 - JP 2017113010-A/3856: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES. MA733771 - JP 2017140048-A/2641: TERMINALLY MODIFIED RNA. MA733800 - JP 2017140048-A/2670: TERMINALLY MODIFIED RNA. MA733816 - JP 2017140048-A/2686: TERMINALLY MODIFIED RNA. MS673476 - Sequence 279 from Patent EP3135774. MS673544 - Sequence 347 from Patent EP3135774. MS834107 - Sequence 253 from Patent EP3112479. MS834123 - Sequence 269 from Patent EP3112479. MS834141 - Sequence 287 from Patent EP3112479. MS901822 - Sequence 295 from Patent EP3156505. MS901865 - Sequence 338 from Patent EP3156505. AY882294 - Homo sapiens microRNA HSA-MIR-RG-64, complete sequence. AY785916 - Homo sapiens microRNA hsa-RG-6, complete sequence. CS548511 - Sequence 1541 from Patent EP1777301. DM174527 - A nucleics Acid regulating cell growth. FV525791 - Nucleic acid controling mast cell degranulation. FW312266 - DETECTING NUCLEIC ACIDS. FW364388 - Oligonucleotides for modulating target RNA activity. HI965003 - Sequence 288 from Patent WO2010139812. HI966432 - Sequence 752 from Patent WO2010139811. HI967298 - Sequence 752 from Patent WO2010139810. HI979157 - Sequence 84 from Patent EP2234483. HV342539 - JP 2011510623-A/84: METHODS AND COMPOSITIONS FOR DIAGNOSING COMPLICATIONS OF PREGNANCY. HV595297 - JP 2010539959-A/678: Micromirs. HW105358 - JP 2013502906-A/55: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF TUMOR INVOLVING CHROMOSOMAL REARRANGEMENTS. HW399363 - WO 2013179672-A/3: Diagnosis of Endometriosis. HW669817 - JP 2013537538-A/548: THERAPEUTIC USES OF MICROVESICLES AND RELATED MICRORNAS. HW818092 - JP 2015500013-A/19: Expression of miRNAs in placental tissue. HW913477 - JP 2015504307-A/237: METHODS OF DIAGNOSING AND TREATING IDIOPATHIC PULMONARY FIBROSIS. HZ074356 - JP 2013535982-A/447: Single-Stranded RNAi Agents Containing an Internal, Non-Nucleic Acid Spacer. HZ157854 - JP 2015130862-A/678: Micromirs. HZ186701 - JP 2015146814-A/450: Oligonucleotides for modulating target RNA activity. HZ482134 - JP 2015535430-A/2640: TERMINALLY MODIFIED RNA. HZ792065 - JP 2016504050-A/3810: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES. JA171099 - Sequence 55 from Patent WO2011023413. JA172744 - Sequence 55 from Patent WO2011023414. JA401041 - Sequence 288 from Patent WO2011080318. JA402019 - Sequence 288 from Patent WO2011080315. JA403026 - Sequence 288 from Patent WO2011080316. JA405657 - Sequence 288 from Patent EP2336353. JA427278 - Sequence 611 from Patent WO2011072177. JA429183 - Sequence 288 from Patent WO2011095623. JB022333 - Sequence 175 from Patent WO2013026685. JB022817 - Sequence 71 from Patent WO2013026684. JB049974 - Sequence 61 from Patent WO2013020926. JB616262 - Sequence 92 from Patent WO2013107459. JB620537 - Sequence 517 from Patent WO2013063544. JB730397 - Sequence 19 from Patent WO2013079701. JB778858 - Sequence 237 from Patent WO2013078283. JC270157 - Sequence 548 from Patent WO2012020307. JC334374 - Sequence 292 from Patent EP2487240. JC514797 - Sequence 5050 from Patent WO2014113089. JE844848 - Sequence 3 from Patent EP2857521. LF161819 - JP 2016513950-A/1885: Oligomers with improved off-target profile. LP727058 - Sequence 752 from Patent EP2883966. LP819328 - Sequence 752 from Patent EP3296406. LP834135 - Sequence 19 from Patent EP3190186. LP939270 - Sequence 752 from Patent EP3184651. LQ072385 - Sequence 2709 from Patent EP2964234. LX270614 - JP 2016056210-A/548: THERAPEUTIC USES OF MICROVESICLES AND RELATED MICRORNAS. LY405362 - KR 1020160117535-A/667: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES. LZ234058 - JP 2017184756-A/450: Oligonucleotides for modulating target RNA activity. MA260601 - JP 2017505623-A/667: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES. MA645886 - JP 2017113010-A/3810: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES. MA730761 - JP 2017125065-A/548: THERAPEUTIC USES OF MICROVESICLES AND RELATED MICRORNAS. MA733770 - JP 2017140048-A/2640: TERMINALLY MODIFIED RNA. MS637986 - Sequence 103 from Patent WO2017037190. MS673268 - Sequence 71 from Patent EP3135774. MS834142 - Sequence 288 from Patent EP3112479. MS901702 - Sequence 175 from Patent EP3156505. MA802944 - JP 2018183181-A/3815: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES. MA802940 - JP 2018183181-A/3811: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES. MA802969 - JP 2018183181-A/3840: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES. MA802985 - JP 2018183181-A/3856: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES. MA802939 - JP 2018183181-A/3810: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES. MB407013 - WO 2019159884-A/503: Kit, device, and method for detection of dementia. MB407413 - WO 2019159884-A/903: Kit, device, and method for detection of dementia. MB406615 - WO 2019159884-A/105: Kit, device, and method for detection of dementia. MB460479 - JP 2018523696-A/8: METHODS AND COMPOSITIONS TO TREAT LIVER DISEASES AND CONDITIONS. MB460480 - JP 2018523696-A/9: METHODS AND COMPOSITIONS TO TREAT LIVER DISEASES AND CONDITIONS. MB460481 - JP 2018523696-A/10: METHODS AND COMPOSITIONS TO TREAT LIVER DISEASES AND CONDITIONS.
| |
|
|
Other Names for This Gene
|
|
Alternate Gene Symbols: ENST00000385014.1, ENST00000385014.2, NR_030211, uc021vao.1, uc021vao.2, uc021vao.3 UCSC ID: ENST00000385014.3 RefSeq Accession: NR_030211
| |
|
|
Methods, Credits, and Use Restrictions
|
|
Click here
for details on how this gene model was made and data restrictions if any.
| |
|
|
|